The worldwide picture of European cannabis is shifting, again.
Back in 2016, there have been hardly any North Americans curious about what had been happening on this side of the Atlantic. A few early movers, such as Tilray’s Brendan Kennedy, have been in London raising money and participating policymakers. Researchers, advocacy groups, and activists composed 95% of their European ‘cannabis industry’.
When Germany legalised medical cannabis in 2017 something shifted. European cannabis, as well as the business opportunities that could include it, were a very real chance. Licences became highly desired and executives in Canadian firms started flying for meetings with politicians, regulators, and in certain instances military colonels.
– Read the whole post at Benzinga.